Keryx Biopharma (KERX) Files $250M Mixed Securities Shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/16/2024
- Dow up on UnitedHealth boost; higher bond yields, Mideast tensions cap gains
- UnitedHealth (UNH) beats earnings, revenue estimates in Q1; shares up
- BofA profit drops as provisions rise, but beats estimates on investment banking surge
- Morgan Stanley (MS) earnings beat lifts stock
- Johnson & Johnson (JNJ) posts mixed results, narrows full-year guidance
- Trump Media & Technology Group (DJT) Files S-1
- Tesla (TSLA) Senior VP Drew Baglino Is Said To Leave The Company - Bloomberg
- General Motors (GM) Said to be Moving Detroit HQ to Dan Gilbert's Hudson Tower - Bloomberg
- GE HealthCare (GEHC) Announces Resignation of Jan Makela, CEO of Imaging
- The Israeli Air Force Has Completed Its Preparation For An Imminent Attack Against Iran - Reuters
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
- After-hours movers: Tesla, Gildan Activewear, Macatawa Bank, and more
- Midday movers: Goldman Sachs and Meta Platforms rise; Apple and Tesla fall
- Nike, Alpine Immune Sciences rise premarket; CarMax, Robinhood and Regeneron fall
Form S-3 KERYX BIOPHARMACEUTICALS
November 9, 2016 7:22 AM ESTTable of Contents
As filed with the Securities and Exchange Commission on November 9, 2016
Registration No. 333-
... More
Form 10-Q KERYX BIOPHARMACEUTICALS For: Sep 30
November 9, 2016 7:20 AM ESTTable of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
... More
Form 8-K KERYX BIOPHARMACEUTICALS For: Nov 09
November 9, 2016 7:16 AM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
... More
